ENG

  • Jim QIU

    Equity Partner / Shanghai

  • Tel +86-21-6061-3666

    Email jimqiu@zhonglun.com

  • Practices

    Compliance & Investigation, Investment/M&A & Corporate Governance, Private Equity & Investment Funds

  • Industries

    Telecommunications & Internet, Healthcare, Pharmaceuticals & Life Sciences

CV

Jim QIU

JIM QIU is a partner from the practice groups of Compliance and Life Science & Healthcare of the firm and resident in the Shanghai office. Mr. Qiu has been dedicated to compliance and risk management services for various transactions and enterprises. He has extensive practice experience in enterprise compliance management and operation, analysis, control and mitigation of compliance risks, compliance review, compliance investigation and due diligence, as well as consultation and support on legal proceedings against compliance violation domestically and overseas.

Mr. Qiu has been serving on a long-term basis many multinational and domestic biotechnology, pharmaceutical, medical device, online medical service and third party medical service enterprises, medical institutions, medical affairs associations, etc. Mr. Qiu and his team’s practices cover the entire circle of the operation of healthcare and life science enterprises, such as industry access and supervision, licensing transaction, product R&D and clinical compliance, healthcare regulatory compliance, product marketing, academic activities, HCP interaction, pharmacovigilance, medical device adverse events, online healthcare, medical malpractice, etc. In addition to the healthcare sector, Mr. Qiu and his team also has good knowledge and experience in the fields of health food, cosmetics, food for specific medical purposes, infant formula food, pet food (including pet prescription food), etc.

Mr. Qiu is the long-term external counsel of all the medical associations and organizations in Shanghai, including Shanghai Medical Association, and also services as a special column writer for the compliance section of LexisNexis, a globally well-known publishing organization.

Representative Matters

Compliance and Regulatory in Medical Healthcare Industry

  • Provided daily and specific legal and compliance services to Sanofi on long-term basis on its China operations

  • Assisted and advised Merck Sharp & Dohme on long-term basis on its daily legal and compliance affairs relating to its China operations

  • Provided specific legal services for the R&D segment of BeiGene on long-term basis

  • Provided specific legal services and regulatory compliance advice for Roche with respect to the digital marketing business

  • Assisted United Imaging on the daily compliance affairs and contract matters

  • Provided legal and compliance advisory services for Stryker on long-term basis in connection with its daily operations

  • Provided long-term legal advice to Smith & Nephew on daily compliance-related affairs

  • Provided legal and compliance advisory service to Hoya/Pentax on its China operations

  • Provided legal and compliance service on long-term basis to the healthcare division of ByteDance

  • Provided legal and compliance advisory services on long-term basis to Tencent Healthcare Affairs Division

  • Provided legal and compliance services on long-term basis to DXY on its China operations

  • Provided daily legal services on long-term basis to the Management Office of All Shanghai Medical Associations (including Shanghai Medical Association, Shanghai Physician Association, Shanghai Chinese Medicine Association, Shanghai Nursing Association, etc.)

  • Assisted a U.S. based global pharmaceutical company on long-term basis in a number of cases regarding the adverse events across the nation

  • Represented a U.S. based pharmaceutical company in a drug quality dispute over adverse drug reactions and medical products

  • Represent a multinational pharmaceutical company in a lawsuit over indemnification disputes against subjects in multi-center clinical trials

  • Provided specific compliance advice to a multinational pharmaceutical company on the bid evaluation matters for centralized volume-based procurement of medicines

  • Provided specific compliance advice to a renowned Israeli medical devices company on the marketing pathway in China of an innovative drug and medical device combined product

  • Represent a Europe-based international pharmaceutical company in leading its nationwide anti-corruption program relating to bribery issues and improvement of its China compliance practices

  • Advised a U.S.- based international medical device company on its commercial bribery investigations across the nation


Compliance Sectors

  • Represented Anheuser-Busch InBev on compliance review and due diligence over a number of acquisition transactions in China

  • Assisted Anheuser-Busch InBev on long-term basis in its daily compliance review of new vendors

  • Advised Luyang Energy-Saving Materials Co., Ltd. (a listed company) on long-term basis on compliance and risk management in all respects of its China operations

  • Assisted many U.S. and Europe-based multinational companies in their China internal anti-bribery investigations and compliance programs

  • Advised many U.S. and Europe-based multinational companies on the potential compliance issues concerning their China distribution systems and sales incentive programs

  • Provided anti-corruption and anti-bribery training to many multinational and domestic companies and advised on the compliance improvement program for their China operations

  • Provided nationwide legal support and assistance to many U.S. and Europe-based multinational companies in governmental investigations on various compliance-related matters

  • Assisted a number of well-known U.S. and Europe-based manufacturing corporations in a nationwide anti-counterfeit program

  • Advised a Europe-based international pharmaceuticals company on investigations against its unfair competition violations across the nation;

  • Advised a well-known Europe-based cosmetic company in a governmental investigation and improvement program relating to a severe safety accident

  • Advised a well-known U.S.-based chemical company in a governmental investigation against its potential environmental violation issue

Honors and Awards

For Individual

Key Lawyers in Healthcare and Life Sciences Sector, Legal 500 Asia-Pacific 2020, 2021 & 2022,

Outstanding Writer of 2021, LexisNexis, (Compliance Sector)

China 100 A-list Lawyers, China Business Law Journal 2016

Memberships & Affiliations

Member of all China Law Society and Shanghai Law Society

Certified Dealmaker of the PRC

Member of Professional Committee of Pharmaceutical and Healthcare Affairs, Shanghai Law Society

Member of Life Science Law Committee, Shanghai Law Society

Member of Competition Law Committee, Shanghai Law Society

Legal Counsel of Shanghai Union Administration Office of Medical Affairs Organizations (the head office of Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, Shanghai Nursing Association, etc.)

Special column writer for the compliance section of LexisNexis

Expert consultant of the Supreme People’s Procuratorate (for civil and administrative cases)

Legal Counsel of Government of Songjiang District, Shanghai

Invited Mediator of Professional People's Mediation Center of Pudong New Area, Shanghai

Publications

“Research and Proposal on Medical Expenses Bearing System during Major Epidemics”, an awarded essay in the essay competition held by Healthcare Legal Service Special Group of All China Lawyers Association;

“Legitimate Handling of Medical Expenses During the Pandemic, selected in Compilation of Studies on Legal Issues Against the Pandemic in the Field of Medical and Healthcare by Medical and Health Committee of Shanghai Bar Association”, published on the website of Shanghai Bar Association;

“Supervision and Legal Risks Regarding Online Diagnosis and Treatment, LexisNexis, selected in The Great Health Industry: Policy, Trends, and Legal Innovations”, published by Law Press China;

“Updates for You: New Rules for Online Diagnosis and Hospital Management”, published on Wolters Kluwer

“Compliance Manual for Anti-Commercial Bribery Practices”, published on LexisNexis

Related

  • Bar Admissions/Professional Qualifications

    PRC Bar
    Certified Dealmaker of the PRC

  • Education

    LL.M., University of Minnesota Law School, Minnesota, U.S.
    LL.B., East China University of Political Science and Law, Shanghai, China

  • Languages

    Chinese
    English